NEW YORK (GenomeWeb) – CombiMatrix announced today that a California court has finalized its recent ruling in the company's favor in an insurance fraud lawsuit.

The suit was filed in the Superior Court of the State of California, County of Orange in 2011 by former CombiMatrix employee Michael Strathmann, who accused the firm, its former CEO Amit Kumar, and former CombiMatrix partner Acacia Research of submitting false and fraudulent insurance claims to National Union Fire Insurance Company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.